scorecardresearch
Friday, September 12, 2025
TopicModerna

Topic: moderna

Even quarter dose of Moderna’s Covid vaccine induces robust immune response, study says

Researchers from a US institute inoculated 35 people with 25 micrograms of the Moderna vaccine and found antibodies six months after vaccination. Standard dose of vaccines is 100 micrograms.

No need to stop breastfeeding, study tells mothers who have received mRNA Covid shots

Researchers from University of California, San Francisco, however, say this is a preliminary study and needs to be repeated with a bigger population.

Cipla gets DCGI nod to import Moderna’s Covid vaccine for restricted emergency use in India

Permission for restricted emergency use potentially opens up a clear possibility of this vaccine being imported to India in the near future, said NITI Aayog Member Dr V K Paul.

Moderna seeks DCGI nod for its Covid vaccine in India, Cipla applies for import & sale

Moderna has also informed that the US govt has agreed to donate a certain number of doses of the Moderna vaccine through COVAX to India.

Pfizer and Moderna vaccines likely to produce long-lasting immunity, study finds

The study, published in the journal Nature, says most people vaccinated with mRNA vaccines may not need booster shots if the virus & its variants don't evolve much beyond their current forms.

In a first, rare blood clot case linked to Moderna mRNA vaccine reported in US

So far, it was thought that only adenoviral vector-based vaccines — such as the AstraZeneca vaccine — caused rare blood clots.

Moderna vaccine effective in 12-17 year-olds, could become 2nd shot approved for teens in US

Moderna says its vaccine showed 93-100% efficacy in preventing symptomatic Covid in a study of teenagers, and no significant safety concerns were observed.

59% Americans support waiving patents for Covid vaccines and life-saving drugs, survey shows

The poll also revealed that a majority of US voters want pharma giant Moderna to share the technology of its taxpayer-funded vaccine.

Modi govt wants more Covid vaccines, but Moderna is ‘not keen’ & Pfizer has this ‘condition’

CSIR has been in talks with Moderna for around 6 months but the company hasn't shown much interest. Pfizer will reassess Modi govt's latest stance on indemnifying vaccine makers.

On Camera

The key difference between India and China’s response to Gen-Z protests in Nepal

China is desperate to keep Communist Nepal ally intact. India must worry.

What’s behind bond yields’ logic-defying spike? The market’s concern over the future

While bond yields tend to fall amid low inflation & interest rate cuts, market experts say they’ve been rising due to concerns over tax collections, fiscal deficit & potential impact of US tariffs.

Navy gets first Tata-made Spanish 3D surveillance radar for its warships, 19 more to come

It is one of the most advanced long-range air defence and anti-missile radars. It has been acquired under an about USD 145-million deal signed in 2020.

Punjab is fast becoming the new Northeast. And there’s a message in it for Modi

In its toughest time in decades because of floods, Punjab would’ve expected PM Modi to visit. If he has the time for a Bihar tour, why not a short visit to next-door Punjab?